Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Supercapsular Percutaneously-Assisted Total Hip (SuperPATH®) Versus Conventional Posterior Approach for Total Hip Arthroplasty: A Prospective Randomized Controlled Study

NCT05147207 is registered in ClinicalTrials.gov with Dr. Gavin Wood as lead sponsor.

NCT NCT05147207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05147207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Supercapsular Percutaneously-Assisted Total Hip (SuperPATH®) Versus Conventional Posterior Approach for Total Hip Arthroplasty: A Prospective Randomized Controlled Study
Lead sponsor
Dr. Gavin Wood
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2017
Completion date
June 1, 2021
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hip arthropathy, surgical approach